Spiegel R. — Psychopharmacology: an introduction :: Электронная библиотека попечительского совета мехмата МГУ

Главная Ex Libris Книги Журналы Статьи Серии Каталог Wanted Загрузка ХудЛит Справка Поиск по индексам Поиск Форум

Авторизация

Поиск по указателям

Spiegel R. — Psychopharmacology: an introduction

Обсудите книгу на научном форуме

Нашли опечатку?
Выделите ее мышкой и нажмите Ctrl+Enter

Название: Psychopharmacology: an introduction

Автор: Spiegel R.

Аннотация:

Describes the latest advances in psychopharmacology - one of the most rapidly developing fields in modern science. This latest edition has been updated to cover new developments in drug therapy and research including newly introduced antipsychotics, antidepressants and antidementia drugs. Sections on the treatment of depression and dementia have been revised to include new developments in treatment strategies. It will be welcomed for its essentially clinical and psychological approach to modern pharmaceuticals, their therapeutic uses and limitations, adverse reactions and future directions for research.

Язык:

Рубрика: Медицина и здравоохранение/

Статус предметного указателя: Готов указатель с номерами страниц

ed2k: ed2k stats

Издание: fouth edition

Год издания: 2003

Количество страниц: 400

Добавлена в каталог: 11.12.2005

Операции: Положить на полку | Скопировать ссылку для форума | Скопировать ID

Предметный указатель

      see carbon dioxide
DASB      Plate 6.2
2-deoxyglucose      209 215
Absorption      see ADME
Accommodation disorders      13
Acetophenazme      5
Acetylcholine (ACh)      37—38 54 110—111 126 255
Acetylcholine (ACh), breakdown of      53
Acetylcholine (ACh), deficiency hypothesis      53
Acetylcholinesterase (AChE)      126
Acne      17
Action potential      103
ADAS      see Alzheimer's Disease Assessment Scale
Adderall $\textregistered$       25
Addiction Severity Index (ASS)      204
Addiction, detoxification      40
ADHD      see attention deficit hyperactivity disorder
ADME (absorption-distribution-metabolism-elimination)      6 105 156—159(157)
Adolept $\textregistered$       5
Adrenaline      37—38 292
Adrenergic receptors      52
Adrenoreceptor antagonist      Plate 6.1
Adumbrant      19
Adverse effects      2 7
Affective disorders      55 180 319—320
Agedal $\textregistered$       11
Aggression      3 20 29 36 251 256 263
Aging, cognitive changes in      252—253
Agitation      10 20 25 41 169 232
Agitation, psychomotor      3
Agonists      108—109
Agonists, group II mGluR      117 125
Agonists, muscarinic      88—89 96
Agoraphobia      291
Agranulocytosis      17 51 307
Akathisia      8 14
Akinesia      8
Alcohol      1—2 10 22 35—36 60—61 162 291
Alcohol, effect on performance      60
Alcohol, ethanol      219
Alcohol, potentiation      20
Alcohol, psychotropic effects of      59
Alcohol, withdrawal from      19
Alcoholism, risk of      35—36
Aldomet $\textregistered$       3
Allergies      38
Allometric scaling      185
Alogia      229 232
Alpha-methyl-par a-ptyrosine (AMPT)      115
Alpha-methyldopa      3
Alprazolam      19 188 294—295
Alraun      34
Alzheimer's disease      50 126 173 188—189 242 253—255
Alzheimer's Disease Assessment Scale (ADAS)      203 254
Alzheimer's disease, and MRI      213
Alzheimer's disease, characteristics of      254
Alzheimer's disease, cholinergic hypothesis of      53 255
Alzheimer's disease, drugs to treat      53—56
Alzheimer's disease, markers for      163—164
Alzheimer's disease, non-cholinergic approaches to      256—259
Alzheimer's disease, risk factors for      254
Alzheimer's disease, treatment approaches      53—54
Alzheimer's disease, vitamin E therapy for      302
Ambient      19
Amenorrhea, caused by antipsychotics      7
Amino acids, in functional imaging      209
Amisulpride      176—177
Amisulpride, effects of      78—79 89
Amitriptyline      10—11
Amitriptyline and depression      126 234—235
Amitriptyline, action spectra of      12
Amitriptyline, effects of      79—82 (80) 95
Amitriptyline, efficacy of      13
Amitriptyline, studies/trials of      275 280—284 287 289
Amnesia      23 242—245 293
Amnesia, anterograde      244
Amnesia, partial      241
Amnesia, retrograde      244
Amoxapine      275
AMPA      117—118
Amphetamines      10
Amphetamines and ADHD      247—250 296—297
Amphetamines and depression      120
Amphetamines and psychoses      24 115 131
Amphetamines, brain metabolism and      217
Amphetamines, dextroamphetamine      25
Amphetamines, discovery/introduction of      36 46
Amphetamines, effects of      85—87 (86) 91
Amphetamines, performance criteria of      86
Amphetamines, side effects of      24
Amphetamines, studies/trials of      73 249
Amyline $\textregistered$       11
Anafranil $\textregistered$       11
Analeptics      2
Analgesics      1—2 3 28 38
Anemia, aplastic      17
Anesthetics      19 28 37—39
Anesthetics, drugs in      242—243
Anger      15
Anhedonia      133
Animal and human behavior, analogies and homologies of      129—130
Animal models for psychiatric indications      128—143
Animal models for psychiatric indications, principles of      129—130
Animal models, non-genetically-based      131—137
Animal models, using genetically altered subjects      137—143
Animal models, using genetically altered subjects, manipulation of genetic background      138—142
Animal models, using genetically altered subjects, selective breeding      137—138
Animal studies, ethical considerations of      130
Animal studies, individuality of subjects      130
Animal studies, manipulation of genetic background      138—142
Animal studies, manipulation of genetic background, possible limitations to      142—143
Animal studies, principles of      129—130
Animal studies, selective breeding for      137—138
Anorexia      14 25 256
Anorgasmia      8
Antagonists      108—109 118
Antagonists, administration of      54
Antagonists, AMPA receptor      117
Antagonists, corticotropin-releasing Factor-1 receptor      122
Antagonists, dopamine      109
Antagonists, kainate receptor      117
Antagonists, neurokinin receptor      121—122
Anti-inflammatory drugs      3 257—258
Anti-inflammatory drugs, non-steroidal (NSAIDs)      257—258
Antianxiety drugs      241—246
Antianxiety drugs, anxiolytic drugs      245—246
Antianxiety drugs, cognitive changes in anxiety disorders      241—242
Antianxiety drugs, effects of benzodiazepines      242—245
Anticholinergic effects      46
Anticonvulsants      16 19 193
Antidementia drugs      2—3 25—26 53 55 94 96 149 252—259
Antidementia drugs and Alzheimer's disease      253—255
Antidementia drugs and Alzheimer's disease, non-cholinergic approaches to      256—259
Antidementia drugs on healthy subjects      91
Antidementia drugs, cholinergic agents      255—256
Antidementia drugs, cognitive changes of aging and dementia      252—253
Antidementia drugs, experiments on      87—89
Antidementia drugs, experiments on behavioral effects      88—89
Antidementia drugs, experiments on neurophysiology      89 96
Antidementia drugs, experiments on subjective effects      87—88
Antidepressant drugs (antidepressants)      1—3 (2) 9—15 41—14 234—241 293—294 319—320
Antidepressant drugs (antidepressants) and anxiety disorders      26
Antidepressant drugs (antidepressants) and depression      18 275—291
Antidepressant drugs (antidepressants) and schizophrenia      18
Antidepressant drugs (antidepressants) on healthy subjects      76 80 90 94
Antidepressant drugs (antidepressants), action spectra of      12 73 149
Antidepressant drugs (antidepressants), activating      10
Antidepressant drugs (antidepressants), best known products      10—11
Antidepressant drugs (antidepressants), clinical actions and uses      9—10
Antidepressant drugs (antidepressants), cognitive changes in depression      234—235

Antidepressant drugs (antidepressants), differential therapeutic effects of      72
Antidepressant drugs (antidepressants), drive-neutral      10
Antidepressant drugs (antidepressants), effects of      95 235—240
Antidepressant drugs (antidepressants), effects of, described      42
Antidepressant drugs (antidepressants), effects of, lithium and mood stabilizers      240—241
Antidepressant drugs (antidepressants), efficacy of      10—14A3)
Antidepressant drugs (antidepressants), experiments on      79—82 263
Antidepressant drugs (antidepressants), experiments on behavioral effects      80—81
Antidepressant drugs (antidepressants), experiments on neurophysiology      81—82
Antidepressant drugs (antidepressants), experiments on subjective effects      79—80
Antidepressant drugs (antidepressants), maintenance therapy      277—278
Antidepressant drugs (antidepressants), mood stabilizers      278—279
Antidepressant drugs (antidepressants), negative aspects of      121
Antidepressant drugs (antidepressants), new      50 52—53 55 271—277
Antidepressant drugs (antidepressants), pharmacokinetics of      156 161
Antidepressant drugs (antidepressants), sedative      10 80—81
Antidepressant drugs (antidepressants), side effects of      (13—14) 14—15 261
Antidepressant drugs (antidepressants), symptom improvement by      263
Antidepressant drugs (antidepressants), tetracyclic      13
Antidepressant drugs (antidepressants), the need for      127—128
Antidepressant drugs (antidepressants), tricyciic      13 53 83 133 162
Antiepileptic drugs (antiepileptics)      161 241
Antihistamines      2 22 37—38 41 118
Antihistamines, effects      46
Antihypertensives      2—3
Antipsychotic drugs (antipsychotics)      1—9 (2) 42 228—234
Antipsychotic drugs (antipsychotics) and depression      18 26
Antipsychotic drugs (antipsychotics) and schizophrenia      18 263—274
Antipsychotic drugs (antipsychotics) and schizophrenia, discontinuation trials      267—269
Antipsychotic drugs (antipsychotics) and schizophrenia, dosage and duration of treatment      264—269
Antipsychotic drugs (antipsychotics) and schizophrenia, drug therapy and psychotherapy      269—274
Antipsychotic drugs (antipsychotics) and schizophrenia, proof of efficacy      263—264
Antipsychotic drugs (antipsychotics) on healthy subjects      58 76 79 89—91 89—90 94
Antipsychotic drugs (antipsychotics), action spectra of      12 149
Antipsychotic drugs (antipsychotics), adverse effects of      7—8
Antipsychotic drugs (antipsychotics), atypical      6 50—52 128
Antipsychotic drugs (antipsychotics), atypical, no studies on      79
Antipsychotic drugs (antipsychotics), best-known products      4—5
Antipsychotic drugs (antipsychotics), brain metabolism and      217
Antipsychotic drugs (antipsychotics), clinical actions and uses      3—4
Antipsychotic drugs (antipsychotics), clinical actions and uses, three phases of      4
Antipsychotic drugs (antipsychotics), cognitive changes in schizophrenia      228—230
Antipsychotic drugs (antipsychotics), depot      267
Antipsychotic drugs (antipsychotics), differential therapeutic effects of      72
Antipsychotic drugs (antipsychotics), dopaminergic mechanism of      115
Antipsychotic drugs (antipsychotics), effects of      95 230—233
Antipsychotic drugs (antipsychotics), efficacy of      263—264
Antipsychotic drugs (antipsychotics), experiments on      76—79 91 263
Antipsychotic drugs (antipsychotics), experiments on behavioral effects      78
Antipsychotic drugs (antipsychotics), experiments on neurophysiology      79 90
Antipsychotic drugs (antipsychotics), experiments on subjective effects      76—78 (77)
Antipsychotic drugs (antipsychotics), new      55
Antipsychotic drugs (antipsychotics), pharmacokinetics of      156 161
Antipsychotic drugs (antipsychotics), product differences      6—7
Antipsychotic drugs (antipsychotics), sedatives      77
Antipsychotic drugs (antipsychotics), side effects of      7—8 261
Antipsychotic drugs (antipsychotics), the need for      127—128
Antipsychotic drugs (antipsychotics), typical      6
Antipyretics      3
Anxiety      2—3 17—21 36 186
Anxiety and stress      124
Anxiety as side effect      14 76
Anxiety in mania      15
Anxiety in psychoses      40
Anxiety, based on conditioned response      134
Anxiety, based on unconditioned response      134—137
Anxiety, disorders      23 26 53 128 166 227
Anxiety, disorders, cognitive changes in      241—242
Anxiety, disorders, medically induced      291
Anxiety, disorders, substance induced      291
Anxiety, dispellation of      10 34 52
Anxiety, levels      97
Anxiety, models of      134—137 143
Anxiety, scales for      199—200
Anxiety, syndromes      90
Anxiety, syndromes, alternatives to benzodiazepine      292—295
Anxiety, syndromes, indications for anxiolytics      291—292
Anxiety, syndromes, nomenclature of      291
Anxiety, syndromes, treatment of      291—296
Anxiolytic drugs (anxiolytics)      2—3 17—23 44 245—246 276 294
Anxiolytic drugs (anxiolytics) as antipsychotics      26
Anxiolytic drugs (anxiolytics) as panaceas      20
Anxiolytic drugs (anxiolytics) on healthy subjects      76 84 90—91 94 179
Anxiolytic drugs (anxiolytics), action spectra of      12
Anxiolytic drugs (anxiolytics), alternatives to benzodiazepine      292—295
Anxiolytic drugs (anxiolytics), antipanic effects of      187
Anxiolytic drugs (anxiolytics), best known products      18 (19)
Anxiolytic drugs (anxiolytics), clinical actions and uses      17—18
Anxiolytic drugs (anxiolytics), differential therapeutic effects of      72
Anxiolytic drugs (anxiolytics), effects of      92 95 242
Anxiolytic drugs (anxiolytics), experiments on      82—85 263
Anxiolytic drugs (anxiolytics), experiments on behavioral effects      83—85 136
Anxiolytic drugs (anxiolytics), experiments on neurophysiology      85
Anxiolytic drugs (anxiolytics), experiments on subjective effects      82—83
Anxiolytic drugs (anxiolytics), fields of application for      20
Anxiolytic drugs (anxiolytics), indications for      291—292
Anxiolytic drugs (anxiolytics), lack of      149
Anxiolytic drugs (anxiolytics), pharmacokinetics of      156 161
Anxiolytic drugs (anxiolytics), psychotherapy, or      18—20
Anxiolytic drugs (anxiolytics), side effects of      20 261
Anxiolytic drugs (anxiolytics), the need for      127—128
Anxiolytic drugs (anxiolytics), withdrawal problems of      21
Apathy      151
Apolipoprotein $\varepsilon4$ (APO $\varepsilon4$ )      254
Apomorphine      115 131
Appetite, increased      14
Appetite, loss of      21
Appetite, suppressants      2
Aricept $\textregistered$       26 53 255
Arousal, levels of      97
ASI      see Addiction Severity Index
Aspartate      110
Assessment methods in drug experiments      61—76
Asthma      293
Astra AB      53
Astrocyies, and neurogenesis      101
Ataxia      17 20 23 45
Ativan $\textregistered$       19
Atropa bellaihnna      34
Atropine      38 221 284
Attenade $\textregistered$       25
Attention and concentration      58 65 185
Attention and concentration, controlled studies      193
Attention and concentration, tests of      66
Attention deficit hyperactivity disorder (ADHD)      2 24—25 87 180 196
Attention deficit hyperactivity disorder (ADHD), amphetamine and      249—250
Attention deficit hyperactivity disorder (ADHD), cognitive abnormalities in      246—247
Attention deficit hyperactivity disorder (ADHD), psychosiimulanis and      247—248
Attention deficit hyperactivity disorder (ADHD), SDL and      250
Attention deficit hyperactivity disorder (ADHD), treatment by psychostimulants      296—298
Attention deficit hyperactivity disorder (ADHD), treatment by psychostimulants, drug therapy and psychotherapy      297—298
Attention deficit hyperactivity disorder (ADHD), treatment by psychostimulants, long-term medication      296—297
Auger scintillation camera      209
Aurorix $\textregistered$       11
Autism      263
Aventyl $\textregistered$       11
Aversive stimulus      137
Avolition      151 229
Bacteria, penicillin-resistant      44
Barbiturates      18 22 38—39 73 157 161 294
Basel University Psychiatric Hospital      39
Bech — Rafelson Mania Scale      202
Beck Depression Inventory      198
Beck, A.T.      283
Beecham      53
BEHAVE-AD      see Behavioural Pathology in Alzheimer's Disease
Behavior, human      227
Behavior, human, cognition      227
Behavior, human, cognition, types of      227
Behavior, human, emotionality      227

1 2 3 4 5 6 7 8

О проекте